Breast cancer awareness should not stop for a pandemic News With falling screening rates and concerns of a wave of post-COVID diagnoses, further preventive health incentives have been put in place. Almost 73,000 fewer mammograms were performed in April 2020 compared to 2018. Since being plunged into a pandemic, Australia has seen a decrease in […]
Read More
Study examines cancer’s effects on young women’s employment and finances Cancer and its treatment can impact an individual’s ability to work, and employment disruptions can lead to financial hardships. A new study indicates that women who were diagnosed with cancer as adolescents or young adults can be especially vulnerable to these effects. The findings are […]
Read More
One drink a day raises risk of alcohol-linked cancers by 10pc There is low community awareness about the link between most of these cancers and alcohol, says Dr Peter Sarich, a post-doctoral research fellow at Cancer Council NSW, who led the study. There is an urgent need to raise awareness of the link between cancer […]
Read More
Expert Reviews New Diagnostic and Staging Criteria in Multiple Myeloma Due to a dramatic paradigm shift in multiple myeloma, the diagnostic and staging criteria have been updated, which represents the considerable impact the latest developments in the field have made on the management of this disease. In 2014, the International Myeloma Working Group (IMWG) published […]
Read More
Optimal Strategies for Treatment of Multiple Myeloma in Newly Diagnosed Patients The multiple myeloma treatment paradigm has seen an assortment of therapeutic advances in recent years with agents that have demonstrated the ability to extend survival in patients and improving disease outcomes. However, the severity of the disease continues to linger without a cure, calling […]
Read More
MorphoSys AG – Consensus Indicates Potential 49.6% Upside MorphoSys AG with ticker code (MOR) now have 1 analysts in total covering the stock. The consensus rating is ‘Buy’. The range between the high target price and low target price is between 43.23 and 43.23 with the average target price sitting at 43.23. Given that the […]
Read More